Turnover: 1.817 million EUR (2017)

Country: France

CellNovo is an independent medical technology company specializing in diabetes, having developed and commercialized an innovative connected mobile diabetes management system that improves patients' lives. The CellNovo insulin pump features an on-screen mobile control device and an integrated blood glucose meter. This connected platform consists of a dedicated Android smartphone that communicates via Bluetooth with the micro insulin pump. CellNovo has sold 1,159 systems since its launch.

The company went into receivership in 2019

Financial Data

DUNS: 808426662

Legal Name: CELLNOVO GROUP

Address: 6 RUE DE TEHERAN , 75008 PARIS 8

Number of employees: Entre 20 et 49 salariés (2018)

Capital: 17 641 765


Financial Data:

Year Turnover (€) Net Profit (€) Fiscal Year End Fiscal Year Duration
2017 1 817 044 EUR -3 732 877 EUR 31/12/2017 12
2016 1 456 060 EUR -3 693 992 EUR 31/12/2016 12
2015 37 840 EUR -2 705 693 EUR 31/12/2015 12

Studies mentioning this company

The Insulin Pump Market - France

Other companies mentioned:

  • Medtronic
  • Cellnovo
  • Roche Diabetes Care (Roche Groupe)
  • Insulet
  • Ypsomed Group
  • ISIS diabète (Isis Médical)
  • Physidia
  • Nova Medical Center
  • Medtrum
  • Apex Wellell
  • Open APS
  • Eli Lilly
  • TreeFrog Therapeutics
  • Boydsense